Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: McNabb Brothers who wrote (5701)	9/25/1998 4:54:00 PM
From: Pete Mason	Respond to of 7041

Yeah, it is interesting how the stock has basically sunk after the so-called great news... Now in the mid 16's, suddenly! Still Short, but with no dysfunction, -- Pete

To: McNabb Brothers who wrote (5701)	9/25/1998 4:57:00 PM
From: Linda Kaplan	Respond to of 7041

Hank, Thanks for the candle reading. Just watching the action, ZONA is showing considerable weakness. It has already lost almost half the gain it made on the positive speculation on the acceptance of the application and the milestone payment. That is, almost half the move from 12-1/4 up to over 19 has been given back now that it has closed near 16 again. I do wish I'd had cash to short shares when it went over 19, but I didn't and I was holding out for 20, anyway. I'll just have to live with my current position, frankly a rare bright spot in an otherwise gloomy trading day today. Linda

To: McNabb Brothers who wrote (5701)	9/26/1998 11:07:00 PM
From: xcr600	Read Replies (1) \| Respond to of 7041

<< Then today it made a dark cloud over hang which is a bearish sign and on a weekly chart it almost left a Doji on a spike point which is very bearish also! >> Huh? What's a Doji spike? I'm not much of a TA guy, obviously. As for the sudden decline- sell the news. I think most people realized the NDA would be accepted, and that the length of the FDA's review (for final drug approval) would just make for an idle investment as a long, especially considering the effectiveness of the drug. (I'm short.)